Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
3.910
-0.270 (-6.46%)
At close: Feb 21, 2025, 4:00 PM
4.200
+0.290 (7.42%)
After-hours: Feb 21, 2025, 7:22 PM EST
Telomir Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -16.53 | -13.07 | -0.85 | -0.14 |
| Other Amortization | 4.34 | 1.61 | - | - |
| Stock-Based Compensation | 6.87 | - | - | - |
| Other Operating Activities | - | 7.49 | - | - |
| Change in Accounts Payable | 0.18 | 0.11 | 0.39 | 0.02 |
| Change in Other Net Operating Assets | -0.06 | -0 | - | - |
| Operating Cash Flow | -5.07 | -3.86 | -0.47 | -0.12 |
| Short-Term Debt Issued | - | 3.12 | 0.46 | 0.12 |
| Total Debt Issued | - | 3.12 | 0.46 | 0.12 |
| Short-Term Debt Repaid | -0.53 | - | - | - |
| Total Debt Repaid | -0.53 | - | - | - |
| Net Debt Issued (Repaid) | -0.53 | 3.12 | 0.46 | 0.12 |
| Issuance of Common Stock | 6.87 | 1 | 0.06 | - |
| Other Financing Activities | - | -0.26 | -0.05 | - |
| Financing Cash Flow | 6.34 | 3.86 | 0.47 | 0.12 |
| Net Cash Flow | 1.26 | -0 | 0 | - |
| Free Cash Flow | -5.07 | -3.86 | -0.47 | -0.12 |
| Free Cash Flow Per Share | -0.17 | -0.14 | -0.02 | - |
| Levered Free Cash Flow | 1.1 | -1.96 | - | - |
| Unlevered Free Cash Flow | -0.53 | -2.55 | - | - |
| Change in Net Working Capital | -0.26 | 0.08 | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.